A Green one-pot three component synthesis of thiazolidine-2,4-dione based bisspirooxindolo-pyrrolidines with [Bmim]BF4: their in vitro and in silico anti-TB studies-Reference-Cited by-同舟云学术

A Green one-pot three component synthesis of thiazolidine-2,4-dione based bisspirooxindolo-pyrrolidines with [Bmim]BF4: their in vitro and in silico anti-TB studies

Published:2024-05-24 Issue: Volume: Page:
ISSN:1381-1991
Container-title:Molecular Diversity
language:en
Short-container-title:Mol Divers

Author:

Rukyanaik V.,Gamidi Rama Krishna,Kumari Jyothi,Sriram Dharmarajan,Basavoju Srinivas

Funder

Council of Scientific and Industrial Research, India

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11030-024-10853-5.pdf

Reference62 articles.

1. World Health Organization (2023) Global tuberculosis report 2023. World Health Organization, Geneva (https://www.who.int/publications/i/item/9789240083851)

2. Komakech K, Nakiyingi L, Fred A, Achan B, Joloba M, Kirenga BJ, Ssengooba W (2024) Effect of mixed mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in uganda. BMC Infect Dis 24:1–8. https://doi.org/10.1186/s12879-023-08968-5

3. Bhowruth V, Dover LG, Besra GS (2007) 4 tuberculosis chemotherapy: recent developments and future perspectives. Prog Med Chem 45:169–203. https://doi.org/10.1016/S0079-6468(06)45504-1

4. Preez ID, Loots DT (2018) Novel insights into the pharmacometabonomics of first-line tuberculosis drugs relating to metabolism, mechanism of action and drug-resistance. Drug Metab Rev 50:466–481. https://doi.org/10.1080/03602532.2018.1559184

5. Molla Y, Wubetu M, Dessie B (2021) Anti-tuberculosis drug induced hepatotoxicity and associated factors among tuberculosis patients at selected hospitals, ethiopia. Hepatic Med Evid Res 13:1–8. https://doi.org/10.2147/hmer.s290542